In the BioHarmony Drug Report Database
Sulfasalazine
Azulfidine, Azulfidine En-tabs (sulfasalazine) is a small molecule pharmaceutical. Sulfasalazine was first approved as Azulfidine on 1982-01-01. It is used to treat juvenile arthritis, rheumatoid arthritis, and ulcerative colitis in the USA. It is known to target proton-coupled folate transporter.
Trade Name
|
Azulfidine, Azulfidine En-tabs |
|---|---|
Common Name
|
sulfasalazine |
ChEMBL ID
|
CHEMBL421 |
Indication
|
juvenile arthritis, rheumatoid arthritis, ulcerative colitis |
Drug Class
|
Antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure; anti-inflammatory agents (salicylic acid derivatives); antimicrobials (sulfonamides derivatives) |
Image (chem structure or protein)